Safety and Efficacy of BRM421 for Dry Eye Syndrome Treatment
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Blair Boehmer, MD
Midwest Cornea Associates, LLC.
Principal Investigator - David Wirta, MD
Eye Research Foundation
Principal Investigator - Eugene B McLaurin, MD
Total Eye Care, PA
Principal Investigator - Gail Torkildsen, MD
Andover Eye Associates
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Eye Research Foundation
Newport Beach, California, United States
- Midwest Cornea Associates, Llc
Indianapolis, Indiana, United States
- Andover Eye Associates
Andover, Massachusetts, United States
- Total Eye Care
Memphis, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Jan 2020
- Primary completion
- 23 Jun 2020
- Completion
- 23 Jun 2020
- Last update posted
- 1 May 2026
- Registered enrollment
- 220
- Registry id
- NCT04343287
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.